Evidence map›Paper›PMID 32328500›Full record

ArticleFrontiers in cardiovascular medicine2020

Comparison of MRI and VQ-SPECT as a Screening Test for Patients With Suspected CTEPH: CHANGE-MRI Study Design and Rationale.

Florian Lasch, Annika Karch, Armin Koch, Thorsten Derlin, Andreas Voskrebenzev, Tawfik Moher Alsady, Marius M Hoeper, Henning Gall, Fritz Roller, Sebastian Harth and 23 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.9field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors at 12 institutions in 4 countries.

Florian LaschInstitute of Biostatistics, Hannover Medical School, Hanover, Germany.
Annika KarchInstitute of Biostatistics, Hannover Medical School, Hanover, Germany.
Armin KochInstitute of Biostatistics, Hannover Medical School, Hanover, Germany.
Thorsten DerlinDepartment of Nuclear Medicine, Hannover Medical School, Hanover, Germany.
Andreas VoskrebenzevDepartment of Diagnostic and Interventional Radiology, Hannover Medical School, Hanover, Germany.
Tawfik Moher AlsadyDepartment of Diagnostic and Interventional Radiology, Hannover Medical School, Hanover, Germany.
Marius M HoeperDepartment of Pneumology, Hannover Medical School, Hanover, Germany.
Henning GallDepartment of Pneumology, Medical University Giessen and Marburg, Giessen, Germany.
Fritz RollerUniversities of Giessen and Marburg Lung Center, Marburg, Germany.
Sebastian HarthUniversities of Giessen and Marburg Lung Center, Marburg, Germany.
Dagmar SteinerDepartment of Nuclear Medicine, Medical University Giessen and Marburg, Giessen, Germany.
Gabriele KrombachUniversities of Giessen and Marburg Lung Center, Marburg, Germany.
Hossein Ardeschir GhofraniDepartment of Pneumology, Medical University Giessen and Marburg, Giessen, Germany.
Fabian RengierDiagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, Germany.
Claus Peter HeußelDiagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, Germany.
Ekkehard GrünigTranslational Lung Research Center (TLRC) Heidelberg, Member of the German Center for Lung Research (DZL), University of Heidelberg, Heidelberg, Germany.
Dietrich BeitzkeDepartment of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.
Marcus HackerDepartment of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.
Irene M LangDepartment of Cardiology, Internal Medicine II, Medical University of Vienna, Vienna, Austria.
Jürgen BehrDepartment of Pneumology, Ludwig-Maximilan University Munich, Munich, Germany.
Peter BartensteinDepartment of Nuclear Medicine, Ludwig-Maximilan University, Munich, Germany.
Julien DinkelComprehensive Pneumology Center, Munich, Ludwig-Maximilians-University Munich and Asklepios Hospital Munich-Gauting and Helmholtz Center Munich, Member of the German Center for Lung Research (DZL), Munich, Germany.
Kai-Helge SchmidtDepartment of Cardiology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Karl-Friedrich KreitnerDepartment of Diagnostic and Interventional Radiology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Thomas FrauenfelderDepartment of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland.
Silvia UlrichDepartment of Respiratory Medicine, Pulmonary Hypertension Unit, University Hospital Zurich, Zurich, Switzerland.
Okka W HamerDepartment of Radiology, Regensburg University Hospital, Regensburg, Germany.
Michael PfeiferDepartment of Pneumology, Regensburg University Hospital, Regensburg, Germany.
Christopher S JohnsAcademic Unit of Radiology, University of Sheffield, Sheffield, United Kingdom.
David G KielySheffield Pulmonary Vascular Disease Unit, Royal Hallamhire Hospital, Sheffield, United Kingdom.
Andrew James SwiftDepartment of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.
Jim WildDepartment of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.
Jens Vogel-ClaussenDepartment of Diagnostic and Interventional Radiology, Hannover Medical School, Hanover, Germany.
Medizinische Hochschule Hannover · DEGerman Center for Lung Research · DEUniversitätsklinikum Gießen und Marburg · DEMedical University of Vienna · ATUniversity of Sheffield · GBJohannes Gutenberg University Mainz · DEUniversities of Giessen and Marburg Lung Center · DEUniversity Hospital Heidelberg · DEUniversity Hospital Regensburg · DELudwig-Maximilians-Universität München · DERoyal Hallamshire Hospital · GBUniversity Hospital of Zurich · CH

Funding

British Heart Foundation SP/14/6/31350Medical Research Council MR/M008894/1Wellcome Trust 205188/Z/16/Z
6 · The paper itself

Abstract

The diagnostic strategy for chronic thromboembolic pulmonary hypertension (CTEPH) is composed of two components required for a diagnosis of CTEPH: the presence of chronic pulmonary embolism and an elevated pulmonary artery pressure. The current guidelines require that ventilation-perfusion single-photon emission computed tomography (VQ-SPECT) is used for the first step diagnosis of chronic pulmonary embolism. However, VQ-SPECT exposes patients to ionizing radiation in a radiation sensitive population. The prospective, multicenter, comparative phase III diagnostic trial

Indexed as

CTEPHdiagnostic strategyMRIPHpulmonary embolismVQ-SPECT

Identifiers

PMID32328500
PMCPMC7161347
OpenAlexW3016157123

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.